Search
for
Sort by
Research 30 of 634
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- Clinical manifestations of cutaneous lupus erythematosus
- The spectrum of cutaneous manifestations in lupus erythematosus—the Italian experience
- Cutaneous lupus erythematosus: a review
- Cutaneous Lupus Erythematosus
- Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
- A Case Report of a Rare Subacute Cutaneous Lupus Erythematosus with Chin Prostration
- Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus
- Skin
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Cutaneous lupus erythematosus
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- Dermatological Presentations in Systemic Lupus Erythematosus: A Comprehensive Case Study
- Clinicopathological characteristics of cutaneous lupus erythematosus patients in Bangladesh
- Clinico-Pathological Profile of Cutaneous Lupus Erythematosus Patients: A Report from A Tertiary Care Center of Chattogram
- Cutaneous lupus erythematosus: clinico-pathologic correlation
- Cutaneous manifestations of systemic lupus erythematosus
- Lupus erythematosus. What’s new?
- Dermoscopy in General Dermatology: A Practical Overview
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- SnapshotDx Quiz: April 2022
- Skin involvement in systemic lupus erythematosus: a review article
- Sub-acute cutaneous lupus erythematosus following nitrofurantoin: causative or coincidental?
- Clinical Patterns of Cutaneous and Mucosal Lesions in Patients with Systemic Lupus Erythematosus
- Lupus erythematosus: systemic and cutaneous manifestations
- CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS FROM A TERTIARY CARE CENTRE IN COASTAL KERALA
- Cutaneous Manifestations of Lupus Erythematosus
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries